Bionano Genomics, Inc. (BNGO) Operating cash flow 2017–2025
Bionano Genomics, Inc. (BNGO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$16.3MFY2025 · since FY2017: -$20.8M → -$16.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.3M | +76.3% |
| FY2024 | -$68.9M | +44.9% |
| FY2023 | -$125.2M | -0.3% |
| FY2022 | -$124.8M | -73.5% |
| FY2021 | -$71.9M | -87.7% |
| FY2020 | -$38.3M | -29.7% |
| FY2019 | -$29.5M | -48.1% |
| FY2018 | -$19.9M | +4.2% |
| FY2017 | -$20.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BNGO financial trends
BNGO RevenueBNGO Net incomeBNGO Net marginBNGO Gross profitBNGO Gross marginBNGO Operating incomeBNGO Operating marginBNGO Free cash flowBNGO Capital expendituresBNGO Return on equityBNGO Stock buybacksBNGO Dividends paidBNGO Total assetsBNGO Total liabilitiesBNGO Shareholders’ equityBNGO overview →